Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Lab901 and Biofortuna announced that they will collaborate on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases such as coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics kits for the detection of Coeliac disease, and other HLA related disease such as reactive arthritis, diabetes and drug hypersensitivity.
Dr Mike Bunce, Biofortuna’s CEO said “We are very excited about the launch of our first line of kits for Coeliac disease susceptibility and Abacavir hypersensitivity. Biofortuna’s blend of easy-to-use one-step PCR technology and multiplexing capability means we are confident of quickly taking market share. Having evaluated several automated systems, we have chosen to work with Lab901 because of the ease-of-use, cost-effectiveness and reproducibility of the ScreenTape platform".
Financial terms were not disclosed.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
Mode of action of the vaccine adjuvant flagellin in fusion proteins has been clarified
Alternative methods replace animal experiments: 20 years successful work by ZEBET within BfR - ZEBET celebrates its anniversary with an international symposium at BfR in Berlin
Imaging the smallest atoms provides insights into an enzyme's unusual biochemistry - This could help in the design of enzymes for the chemical industry
Clever biomolecular labelling enables identification of immune cells - New strategy for labelling peptides
Method aims to predict allergenic potency of chemicals
QIAGEN partners with sequencing provider
Making cars and airplanes cheaper, safer and more efficient - DFG funds 2 major instruments to test components made of fiber-reinforced composites
Enterome and Nestlé Health Science launch new diagnostics company
New wheat diversity discovery could provide an urgently-needed solution to global food security - Newly-discovered diversity in the wheat genome could offer vital new opportunities to improve and ‘climate-proof’ one of the world’s most important staple crops
Hidden properties of solids